Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dovobet gel
1305020D0BCABAG
|
Dovobet | Calcipotriol | Skin | 24,210 |
|
Hydrocortisone 1% / Miconazole 2% ointment
1304000V0AACSCS
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 24,062 |
|
Diprosalic 0.05%/3% ointment
1304000D0BCAABB
|
Diprosalic | Betamethasone esters | Skin | 23,234 |
|
Diclofenac sodium 3% gel
1308010W0AAAAAA
|
Diclofenac sodium (Actinac Keratosis) | Diclofenac sodium | Skin | 22,781 |
|
Adapalene 0.1% cream
1306010H0AAABAB
|
Adapalene | Adapalene | Skin | 22,577 |
|
Conotrane cream
1302020D0BBAAAC
|
Conotrane | Dimeticone (Barrier) | Skin | 22,032 |
|
Ivermectin 10mg/g cream
1306030B0AAAAAA
|
Ivermectin (Skin) | Ivermectin | Skin | 21,350 |
|
Solaraze 3% gel
1308010W0BBAAAA
|
Solaraze | Diclofenac sodium | Skin | 21,032 |
|
Elocon 0.1% ointment
1304000Y0BBABBA
|
Elocon | Mometasone furoate | Skin | 20,732 |
|
Metronidazole 0.75% cream
1310012K0AAAXAX
|
Metronidazole (Topical) | Metronidazole | Skin | 20,600 |
|
Azelaic acid 20% cream
1306010B0AAAAAA
|
Azelaic acid | Azelaic acid | Skin | 19,969 |
|
Oilatum Junior bath additive
1302011L0BKAFAI
|
Oilatum | Light liquid paraffin | Skin | 19,847 |
|
Azelaic acid 15% gel
1306010B0AAABAB
|
Azelaic acid | Azelaic acid | Skin | 19,746 |
|
Ketoconazole 2% cream
1310020L0AAAAAA
|
Ketoconazole (Skin) | Ketoconazole | Skin | 18,785 |
|
Menthol 1% in Aqueous cream
1303000AAAAABAB
|
Menthol (Topical) | Menthol | Skin | 18,267 |
|
Betacap 0.1% scalp application
1304000F0BDAABD
|
Betacap | Betamethasone valerate | Skin | 18,120 |
|
Hydrocortisone 0.5% cream
1304000V0AAACAC
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 18,072 |
|
Duac Once Daily gel (3% and 1%)
1306010Y0BBABAB
|
Duac | Benzoyl peroxide and clindamycin phosphate | Skin | 17,792 |
|
Dermol Wash cutaneous emulsion
130201100BBBAAN
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 17,663 |
|
Diprosalic 0.05%/2% scalp application
1304000D0BCABBD
|
Diprosalic | Betamethasone esters | Skin | 17,194 |
|
Betnovate RD 0.025% cream
1304000F0BBADAB
|
Betnovate (Topical) | Betamethasone valerate | Skin | 17,152 |
|
Coal tar extract 2% shampoo
1309000C0AAANAN
|
Coal tar (Scalp) | Coal tar | Skin | 16,952 |
|
Tacrolimus 0.03% ointment
1305030C0AAACAC
|
Tacrolimus (Topical) | Tacrolimus | Skin | 16,826 |
|
Soolantra 10mg/g cream
1306030B0BBAAAA
|
Soolantra | Ivermectin | Skin | 16,818 |
|
Protopic 0.1% ointment
1305030C0BBAAAA
|
Protopic | Tacrolimus | Skin | 16,743 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.